News

  • Letter to Glenn Hackbarth Regarding MedPAC PFS Comments

    September 24, 2013
    Glenn M. Hackbarth, J.D., Chairman Medicare Payment Advisory Commission 425 Eye Street, NW, Suite 701 Washington, DC 20001 Dear Chairman Hackbarth: The American Clinical Laboratory Association is taking this opportunity to share our views on the recent comments submitted to the Centers for Medicare and Medicaid Services (“CMS”) by the Medicare Payment Advisory Commission (“MedPAC” or “the Commission”) with regard to the 2014 MedicareContinue Reading »...
  • ACLA Submits Comments to CMS on Physician Fee Schedule, Clinical Laboratory Fee Schedule Calls For Adequate Reimbursement for Diagnostic Services

    September 03, 2013
    WASHINGTON D.C. – The American Clinical Laboratory Association (ACLA) submitted comments to the Centers for Medicare & Medicaid Services (CMS) urging the use of reimbursement policies that recognize the essential role of diagnostic services in the healthcare delivery system and protects access to these vital services for Medicare beneficiaries. In July CMS issued a rule proposing revisions to payment policies for the Medicare ProgramContinue Reading »...
  • Comments to CMS Regarding Lab Issues ESRD PPS

    August 30, 2013
    Laurence Wilson Director, Chronic Care Policy Group Center for Medicare Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Dear Mr. Wilson: On behalf of the members of the American Clinical Laboratory Association (“ACLA”), many of whom provide services to end stage renal disease (“ESRD”) beneficiaries on renal dialysis, I am writing to express our concerns about post-regulatory issuances by theContinue Reading »...
  • Letter to Marilyn Tavenner regarding PFS Comments

    August 29, 2013
    Administrator Marilyn Tavenner Centers for Medicare and Medicaid Services Department of Health and Human Services Room 445-G Hubert H. Humphrey Building 200 Independence Avenue SW Washington, DC 20201 RE: Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, and Other Revisions to Part B for CY 2014, Proposed Rule (CMS-1600-P) Dear Ms. Tavenner, The American Clinical Laboratory AssociationContinue Reading »...
  • New Analysis Finds Contradictions and Flaws in CMS Rationale for Cutting Anatomic Pathology Services for Medicare Beneficiaries

    August 20, 2013
      WASHINGTON D.C. – Today the American Clinical Laboratory Association (ACLA) released a report prepared by The Moran Company, a research firm with expertise in Medicare, that found serious contradictions and flaws in a recent proposal from the Centers for Medicare & Medicaid Services (CMS) to drastically cut Medicare reimbursement for anatomic pathology services. On July 8, CMS issued a rule proposing to cutContinue Reading »...
  • Joint Statement by AIM for Integrity in Medicare Applauding the Introduction of the Promoting Integrity in Medicare Act of 2013

    August 01, 2013
    The Alliance for Integrity in Medicare (AIM)— a broad coalition of medical specialty, laboratory, radiation oncology, and medical imaging groups committed to ending the practice of inappropriate physician self-referral – applauds the strong leadership of U.S. Representative Jackie Speier (D-CA14) as demonstrated through the introduction of The Promoting Integrity in Medicare Act of 2013. AIM supports this legislation, which addresses the ongoing misapplication ofContinue Reading »...
  • AIM Letter to Rep. Speier on Promoting Integrity in Medicare Act of 2013

    August 01, 2013
      The Honorable Jackie Speier U.S. House of Representatives 211 Cannon House Office Building Washington,DC 20515 Dear Representative Speier: On behalf of the members of the Alliance for Integrity in Medicare (AIM) — a broad coalition of medical specialty, laboratory, radiation oncology, and medical imaging groups committed to ending the practice of inappropriate physician self-referral — we thank you for introducing The Promoting IntegrityContinue Reading »...
  • Joint Statement By The Alliance For Integrity In Medicare Applauding THE Introduction Of The Promoting Integrity In Medicare Act Of 2013 By U.S. Representative Jackie Speier (D-CA14)

    August 01, 2013
    JOINT STATEMENT BY THE ALLIANCE FOR INTEGRITY IN MEDICARE APPLAUDING THE INTRODUCTION OF THE PROMOTING INTEGRITY IN MEDICARE ACT OF 2013 BY U.S. REPRESENTATIVE JACKIE SPEIER (D-CA14) August 1, 2013 The Alliance for Integrity in Medicare (AIM)— a broad coalition of medical specialty, laboratory, radiation oncology, and medical imaging groups committed to ending the practice of inappropriate physician self-referral – applauds the strong leadershipContinue Reading »...
  • Comment on Promoting Integrity in Medicare Act of 2013

    July 30, 2013
    The Honorable Jackie Speier U.S. House of Representatives 211 Cannon House Office Building Washington, DC 20515 Dear Representative Speier: The American Clinical Laboratory Association (ACLA) represents the nation’s leading local, regional and national laboratories, many of whom provide anatomic pathology services. Therefore, we thank you for introducing The Promoting Integrity in Medicare Act of 2013, which realigns provider incentives to preclude self-referral by noContinue Reading »...
  • Labs Surprised By CMS’ Proposed 25% Pay Cut For Diagnostic Lab Tests

    July 18, 2013
    Laboratories are up in arms over CMS’ unexpected proposal this week to cut pay for lab tests by 25 percent, but CMS Medicare chief Jonathan Blum said the diagnostics have been overvalued because CMS up to now has not factored in technological changes that bring down the cost of tests. CMS proposes in the new laboratory fee schedule rule a process to adjust payContinue Reading »...